BLU-945 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
BLU-945 is a potent, highly selective, reversible, and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It can effectively inhibit EGFR with L858R and/or exon 19 deletion mutation, T790M mutation, and C797S mutation. BLU-945 can be used for research on lung cancer, including non-small cell lung cancer (NSCLC)[1].
BLU-945 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte